Marinus Pharmaceuticals (MRNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
According to Jancee Dunn “Nearly three-quarters of the food supply in the U.S. is ultra-processed, according to one estimate published in the journal Nature Communications. Research suggests that ...